ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Impact of Crime Group Intervention for Jail Inmates (IOC-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01380977
Recruitment Status : Unknown
Verified May 2013 by June Tangney, George Mason University.
Recruitment status was:  Active, not recruiting
First Posted : June 27, 2011
Last Update Posted : May 7, 2013
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
June Tangney, George Mason University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This pilot study is designed to evaluate the efficacy of the Impact of Crime (IOC) group intervention for jail inmates. The hypothesis is that participants in IOC will show decreases in criminogenic thinking, decreases in shame, increases in guilt, and increases in empathy, which in turn will be reflected in reduced recidivism (official records and self report), relative to those randomly assigned to a treatment as usual group.

Condition or disease Intervention/treatment Phase
Crime Substance Abuse HIV Risk Criminogenic Thinking Shame Behavioral: Impact of Crime group intervention Phase 1 Phase 2

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 51 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : August 2002
Estimated Primary Completion Date : August 2013
Estimated Study Completion Date : July 2016
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Impact of Crime group intervention Behavioral: Impact of Crime group intervention
A group intervention for 16 1.5 hr sessions held twice a week
Active Comparator: Treatment as usual Behavioral: Impact of Crime group intervention
A group intervention for 16 1.5 hr sessions held twice a week


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Self reported recidivism (arrests and undetected offenses) [ Time Frame: 1 year post-release up to 2 yrs post release ]
  2. Self reported recidivism (arrests and undetected offenses) [ Time Frame: 4 years post-release up to 5 yrs post release ]
  3. Self reported recidivism (arrests and undetected offenses) [ Time Frame: 7 years post-release up to 8 yrs post-release ]
  4. Self reported recidivism (arrests and undetected offenses) [ Time Frame: 10 years post-release up to 11 yrs post-release ]
  5. Self-reported Substance Use and Dependence - TCU [ Time Frame: 1 year post-release up to 2 yrs post-release ]
  6. Self-reported Substance Use and Dependence - TCU [ Time Frame: 4 years post-release up to 5 yrs post-release ]
  7. Self-reported Substance Use and Dependence - TCU [ Time Frame: 7 years post-release up to 8 yrs post-release ]
  8. Self-reported Substance Use and Dependence - TCU [ Time Frame: 10 years post-release up to 11 yrs post release ]
  9. Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 1 year post-release - up to 2 yrs post-release ]
  10. Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 4 years post-release up to 5 yrs post-release ]
  11. Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 7 years post-release up to 8 yrs post-release ]
  12. Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 10 years post-release up to 11 yrs post-release ]

Secondary Outcome Measures :
  1. Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to post-treatment up to 9 mos ]
  2. Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to pre-release up to 1.5 yrs ]
  3. Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 1 yr post-release up to 3.5 yrs ]
  4. Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 4 yrs post-release up to 6.5 yrs ]
  5. Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 7 yrs post-release up 9,5 yrs ]
  6. Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 10 yrs post-release up to 12.5 yrs ]
  7. Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to post-treatment up to 9 mos ]
  8. Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to pre-release up to 1.5 yrs ]
  9. Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 1 yr post release up to 3.5 yrs ]
  10. Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 4 yrs post release up to 6.5 yrs ]
  11. Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 7 yrs post release up to 9.5 yrs ]
  12. Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 10 yrs post release up to 12.5 yrs ]
  13. Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to post-treatment up to 9 mos ]
  14. Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to pre-release up to 1.5 yrs ]
  15. Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 1 yr post-release up to 3.5 yrs ]
  16. Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 4 yrs post-release up to 6.5 yrs ]
  17. Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 7 yrs post-release up to 9.5 yrs ]
  18. Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 10 yrs post-release up to 12.5 yrs ]
  19. Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to post-treatment up to 9 mos ]
  20. Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to pre-release up to 1.5 yrs ]
  21. Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 1 year post-release up to 3.5 yrs ]
  22. Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 4 years post-release up to 6.5 yrs ]
  23. Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 7 years post-release up to 9.5 yrs ]
  24. Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 10 years post-release up to 12.5 yrs ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01380977


Locations
United States, Virginia
Fairfax County Adult Detention Center
Fairfax, Virginia, United States, 22030
Sponsors and Collaborators
George Mason University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: June P Tangney, Ph.D. George Mason University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: June Tangney, Professor, George Mason University
ClinicalTrials.gov Identifier: NCT01380977     History of Changes
Other Study ID Numbers: R01DA014694-1
R01DA014694 ( U.S. NIH Grant/Contract )
First Posted: June 27, 2011    Key Record Dates
Last Update Posted: May 7, 2013
Last Verified: May 2013

Keywords provided by June Tangney, George Mason University:
crime
substance abuse
HIV risk
criminogenic thinking
 shame
guilt
restorative justice
victim impact group

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders